Medicare Enrolled

Dr. Herbert Duvivier, M.D.

Hematology & Oncology · Cheektowaga, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3085 HARLEM RD STE 300, Cheektowaga, NY 14225
7164425422
In practice since 2005 (21 years)
NPI: 1710982731 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Duvivier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Duvivier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Duvivier

Dr. Herbert Duvivier is a hematology & oncology specialist in Cheektowaga, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Duvivier performed 816 Medicare services across 411 unique beneficiaries.

Between the years covered by Open Payments, Dr. Duvivier received a total of $175,520 from 54 pharmaceutical and/or device companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Duvivier is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 47% volume in NY $175,520 industry payments

Medicare Practice Summary

Medicare Utilization ↗
816
Medicare services
Top 47% in NY for hematology & oncology
411
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
589 $70 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
186 $45 $263
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $95 $640
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $63 $379
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $109 $564
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$175,520
Total received (2018-2024)
Avg $25,074/year across 7 years
Top 5% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
714
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114,886 (65.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,721 (30.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,913 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$617
2023
$8,663
2022
$17,310
2021
$16,647
2020
$8,398
2019
$53,622
2018
$70,263

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$117
Janssen Biotech, Inc.
$114
Amgen Inc.
$114
GlaxoSmithKline, LLC.
$113
Astellas Pharma US Inc
$99
Incyte Corporation
$61
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$66,657
AstraZeneca Pharmaceuticals LP
$49,720
Regeneron Healthcare Solutions, Inc.
$19,373
Bayer HealthCare Pharmaceuticals Inc.
$16,867
Puma Biotechnology, Inc.
$5,360
Rigel Pharmaceuticals, Inc.
$3,873
Daiichi Sankyo Inc.
$3,238
GENZYME CORPORATION
$1,703
Novartis Pharmaceuticals Corporation
$1,132
Janssen Biotech, Inc.
$754
Amgen Inc.
$652
PFIZER INC.
$632
BeiGene USA, Inc.
$569
Genentech USA, Inc.
$503
Astellas Pharma US Inc
$472
Incyte Corporation
$425
E.R. Squibb & Sons, L.L.C.
$405
GlaxoSmithKline, LLC.
$320
Pharmacyclics LLC, An AbbVie Company
$263
Sirtex Medical Inc
$230
Lilly USA, LLC
$209
Eisai Inc.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Coherus Biosciences Inc.
$133
Dendreon Pharmaceuticals LLC
$122
Celgene Corporation
$117
Takeda Pharmaceuticals U.S.A., Inc.
$117
Bayer Healthcare Pharmaceuticals Inc.
$111
Gilead Sciences, Inc.
$110
Alexion Pharmaceuticals, Inc.
$110
Jazz Pharmaceuticals Inc.
$110
Mirati Therapeutics, Inc.
$108
Medical Device Business Services, Inc.
$100
TESARO, Inc.
$71
Exelixis Inc.
$70
Shire North American Group Inc
$70
Janssen Pharmaceuticals, Inc
$60
AbbVie, Inc.
$56
Seattle Genetics, Inc.
$48
Grifols USA, LLC
$38
Taiho Oncology, Inc.
$31
Novocure Inc.
$31
Heron Therapeutics, Inc.
$29
SANOFI-AVENTIS U.S. LLC
$28
EMD Serono, Inc.
$26
Sun Pharmaceutical Industries Inc.
$26
Helsinn Therapeutics (U.S.), Inc.
$25
Verastem, Inc.
$24
Clovis Oncology, Inc.
$23
Seagen Inc.
$18
Kite Pharma, Inc.
$17
Ethicon US, LLC
$15
AMAG Pharmaceuticals, Inc.
$13
Dova Pharmaceuticals
$11
Top 3 companies account for 77.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BOSULIF · BRUKINSA · Balversa · Bavencio · CABLIVI · CERDELGA · CEREZYME · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ERLEADA · Enhertu · Erleada · FEIBA · FERAHEME · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gamunex-C · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · Istodax · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MOVANTIK · MVASI · MYLOTARG · NINLARO · NOXAFIL · Nerlynx · Neulasta · Nexavar · Nplate · OBIZUR · ODOMZO · OPDIVO · Oncology · Optune · PADCEV · PIQRAY · PROMACTA · PROVENGE · Padcev · Perjeta · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIVDAK · Tavalisse · Turalio · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XTANDI · Xofigo · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for hematology & oncology in NY.

Looking for a hematology & oncology specialist in Cheektowaga?
Compare hematology & oncology specialists in the Cheektowaga area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
21
Per 100K population
2.2
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Duvivier is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NY peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Duvivier experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Duvivier performed 589 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Duvivier receive payments from pharmaceutical companies?
Yes. Dr. Duvivier received a total of $175,520 from 54 companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Duvivier's costs compare to other hematology & oncology specialists in Cheektowaga?
Dr. Duvivier's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Duvivier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →